106
Participants
Start Date
November 22, 2022
Primary Completion Date
May 20, 2025
Study Completion Date
May 20, 2025
Model C0002
Eligible subjects will be randomized in a 1:1 ratio to the investigational IOL Model C0002 in both eyes for the duration of the study.
Model ZCB00/DCB00
Eligible subjects will be randomized in a 1:1 ratio to the control IOL Model ZCB00 in both eyes for the duration of the study.
Centre Hospitalier National d'Ophtalmologie, Paris
Rothschild Foundation Hospital, Paris
Johnson & Johnson Surgical Vision, Inc.
INDUSTRY